Entero Therapeutics, Inc.

Entero Therapeutics, Inc. designs and develops an AI-driven software and device platform that helps utilities, retailers, and large power users manage load and distributed energy resources. Its Aggregation Management Platform uses IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also conducts research and development of targeted and non-systemic therapies for patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries, and is based in Edinburgh, United Kingdom, with additional offices in Prague, Czechia, and Mississauga, Canada.